DUBLIN, Jan. 28, 2019 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced dosing of
Continue reading »
25-year study shows that incidence of type 1 diabetes is increasing by more than 3 percent per year in Europe
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) shows that new
Continue reading »
Argenx Doses First Patient in Global Phase 3 Registration Trial of Efgartigimod
September 06, 2018 — Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company
Continue reading »
Breast Cancer Drug Promising in Phase 3 Trial
WEDNESDAY, Aug. 15, 2018 — For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an
Continue reading »
Brave 11-year-old boy dies of cancer after 3-year battle
Brave 11-year-old boy who was fighting a rare form of cancer, at the same time as his mother, dies at
Continue reading »
Omega-3 supplements make children better behaved, study finds
Omega-3 supplements make children better behaved by improving their brain health: Study finds they are less likely to disobey instructions,
Continue reading »
'Will A Baby Destroy My Sex Life? And 3 Other Things That Terrify Me About Becoming A Mother'
I’m 28 weeks pregnant and despite feeling positively elated, I’m also downright scared. What am I worried about? Oh, you
Continue reading »
Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
BOSTON, June 14, 2018 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization
Continue reading »
1 in 3 women experience ‘loss of control’ eating in pregnancy
More than a third of women report feeling out of control over the amount they eat during pregnancy, according to
Continue reading »
3,000 NHS patients waiting on operations or treatment for over a year
Now 3,000 NHS patients waiting on operations or treatment for more than a year – the highest figure since 2012,
Continue reading »